Cardiovascular Inflammation Reduction Trial (CIRT): A Randomized Double-Blind Placebo-Controlled, Event-Driven Trial of Weekly Low-Dose Methotrexate (LDM) in the Prevention of Recurrent Cardiovascular Events Among Stable Post-Myocardial Infarction Patients

Grant

Date/time Interval

  • February 1, 2013 - January 31, 2018
  • Total Award Amount

  • 102000.00
  • Direct Costs

  • 69388.00
  • Sponsor Award Id

  • Contributor

  • Ovalle, Fernando   Principal Investigator  
  • Vaughan, Tom   Investigator  
  • Warriner, Amy   Investigator